Goldman Sachs’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Goldman Sachs’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-40,000	Closed	-$806K	–	6191
2018 Q1	$806K	Hold	40,000	–	–	﹤0.01%	4183
2017 Q4	$803K	Buy	40,000 +39,200	+4,900%	+$771K	﹤0.01%	4470
2017 Q3	$17K	Sell	800 -300	-27%	-$5.07K	﹤0.01%	6454
2017 Q2	$16K	Buy	+1,100	New	+$18.3K	﹤0.01%	6596
2016 Q2	–	Sell	-900	Closed	-$25K	–	7374
2016 Q1	$25K	Hold	900	–	–	﹤0.01%	6687
2015 Q4	$31K	Sell	900 -43,000	-98%	-$1.34M	﹤0.01%	6740
2015 Q3	$1.26M	Buy	43,900 +36,100	+463%	+$1.54M	﹤0.01%	4243
2015 Q2	$349K	Buy	+7,800	New	+$293K	﹤0.01%	5592

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Goldman Sachs's DPLO Position: Q1 2020 in Review

Goldman Sachs sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 563,003 shares — an estimated $2.25M sold.

Goldman Sachs first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $8.86M in Q1 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Goldman Sachs reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Goldman Sachs sold 563,003 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2.25M.
Goldman Sachs first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
Goldman Sachs's DIPLOMAT PHARMACY, INC. position peaked at $8.86M in Q1 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.